In humans, TRAIL binds to death domains that can either induce caspase-dependent programmed cell death (apoptosis) in transformed/tumor cells or activate Nuclear Factor kappa B (NFκB) signaling which mediates the cellular inflammatory response (Sonar and Lal, 2015). The gene discussed is TNFSF10; the disease is neoplasm.